The dawn of targeted therapy for primary myelofibrosis: opportunities and challenges.
Mesa
Ruben A
RA
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D055728:Primary Myelofibrosis / Q000188:drug therapy*
D000970:Antineoplastic Agents